Are there multiple people in your family with congenital heart defects (heart problems that they were born with)? Are you and your relatives willing to have your blood drawn? If you answered yes to both of these questions, then we would like to invite you to participate in our research study call “Genetic Testing of Individuals and Families with Congenital Heart Disease.”
Most heart defects are caused by one or more genes working together with one or more environmental factors during pregnancy. Through this study, we hope to understand how genes and changes in those genes might cause the heart defects. We are interested in families that have multiple people with heart defects as it is easier to find the genetic cause when we examine the genetic material (also called DNA) of multiple biologic (blood) relatives. We hope by understanding genes that can cause heart defects we can then learn how to prevent these defects from happening in other children.
Ideally, all of the individuals in the family with heart defects, their parents and the connecting relatives would all participate. If some individuals are not available to participate (deceased, not in contact, etc.) your family may still be able to participate.
Those who would like to participate will need to have their blood drawn (at a hospital convenient to you and at no cost). Additionally, they should be willing to discuss how many relatives they have, their ages and if any of them have heart problems.
It will not cost you anything to be in this study. The study will pay for your blood draw. You will not be compensated for participating in this study.
More detailed information about the study is available in the study consent form. If you have questions, would like more information or would like to be part of this study, please submit your contact information below and a study staff member will contact you.
Meet the Team
Center for Molecular and Human Genetics
Cardiovascular Genetics Clinic
In conjunction with the section of Molecular and Human Genetics, cardiology evaluation, treatment and follow up services have been available and continue to be available to patients with genetic disorders since 2004.